Dow Up 0.36% Nasdaq Up 0.12%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
15.08 Down 0.20(1.31%) 4:00PM EDT
|After Hours : 15.08 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
Prev Close:15.28
Open:15.32
Bid:15.08 x 600
Ask:15.09 x 300
1y Target Est:22.67
Beta:0.06
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:14.79 - 15.40
52wk Range:8.57 - 20.29
Volume:404,513
Avg Vol (3m):515,158
Market Cap:1.14B
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXDown 1.31%1.14B
ABTUp 0.43%63.64B
LLYUp 0.03%66.48B
PFEDown 0.24%182.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):795.09
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.81
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback